IBDEI0TH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14554,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,14554,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,14554,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,14555,0)
 ;;=V12.54^^90^861^56
 ;;^UTILITY(U,$J,358.3,14555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14555,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,14555,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,14555,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,14556,0)
 ;;=V12.54^^90^861^52
 ;;^UTILITY(U,$J,358.3,14556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14556,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,14556,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,14556,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,14557,0)
 ;;=V15.88^^90^861^33
 ;;^UTILITY(U,$J,358.3,14557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14557,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,14557,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,14557,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,14558,0)
 ;;=V13.59^^90^861^42
 ;;^UTILITY(U,$J,358.3,14558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14558,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,14558,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,14558,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,14559,0)
 ;;=V15.52^^90^861^55
 ;;^UTILITY(U,$J,358.3,14559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14559,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,14559,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,14559,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,14560,0)
 ;;=V12.04^^90^861^38
 ;;^UTILITY(U,$J,358.3,14560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14560,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,14560,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,14560,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,14561,0)
 ;;=V13.51^^90^861^23
 ;;^UTILITY(U,$J,358.3,14561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14561,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,14561,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,14561,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,14562,0)
 ;;=V15.51^^90^861^58
 ;;^UTILITY(U,$J,358.3,14562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14562,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,14562,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,14562,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,14563,0)
 ;;=V62.22^^90^861^49
 ;;^UTILITY(U,$J,358.3,14563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14563,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,14563,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,14563,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,14564,0)
 ;;=V70.0^^90^862^1
 ;;^UTILITY(U,$J,358.3,14564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14564,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,14564,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,14564,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,14565,0)
 ;;=V77.91^^90^862^2
 ;;^UTILITY(U,$J,358.3,14565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14565,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,14565,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,14565,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,14566,0)
 ;;=V76.44^^90^862^3
 ;;^UTILITY(U,$J,358.3,14566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14566,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,14566,1,5,0)
 ;;=5^Screen for Prostate CA
 ;;^UTILITY(U,$J,358.3,14566,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,14567,0)
 ;;=V74.5^^90^862^5
 ;;^UTILITY(U,$J,358.3,14567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14567,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,14567,1,5,0)
 ;;=5^Screening for STD's
 ;;^UTILITY(U,$J,358.3,14567,2)
 ;;=Screening for STD's^295637
